Abstract:Study question: What is the direct genetic contribution of the polycystic ovary syndrome (PCOS) susceptibility single nucleotide polymorphisms (SNPs), identified by previous genome-wide association studies (GWAS) to the definitive clinical features of the syndrome? Summary answer: Each single PCOS clinical feature had a specific genetic association, and rs4385527 in the chromosome 9 open reading frame 3 (C9orf3) conferred a particular risk to the three defined PCOS clinical features in this study, which suggested its fundamental role in the etiology of PCOS. What is known already: PCOS is a heterogeneous disorder characterized by anovulation (OA), hyperandrogenism (HA) and polycystic ovary morphology (PCOM). Two previous GWAS in China have identified 15 independent susceptibility SNPs related to PCOS (PCOS-SNPs). However, little is known about the candidate gene of each clinical feature. Study design, size, duration: Case-control study. Three independent groups of women were recruited from 2010 to 2012: 746 subjects with OA only, 278 subjects with HA only and 536 subjects with PCOM only. A total of 1790 healthy women with none of the above pathological characteristics were also enrolled as control subjects during the same time period. Participants/materials, setting, methods: All participants were women of reproductive age. Genotype and allelic frequencies of 15 PCOS-SNPs were determined in all subjects using direct sequencing and Sequenom Arrays. The allelic frequencies of each case group were compared with the controls. Main results and the role of chance: After adjustment for age and BMI, variants in luteinizing hormone/choriogonadotropin receptor (LHCGR) (rs13405728), C9orf3 (rs4385527) and insulin receptor gene (INSR) (rs2059807) were strongly associated with OA (Padjust < 0.01, <0.001 and <0.05, respectively); rs4385527 in C9orf3 was strongly associated with HA (Padjust< 0.001); variants in the thyroid adenoma associated gene (THADA) (rs13429458 and rs12478601), DENN/MADD domain containing 1A (DENND1A)(rs10818854), and C9orf3 (rs4385527) were significantly associated with PCOM (Padjust < 0.01, <0.001, <0.05 and <0.001, respectively). Limitations, reasons for caution: The sample size of some case groups was relatively small, which therefore limited the statistical power of the analysis to a certain extent. Wider implications of the findings: The present study indicates a potential common genetic basis of three PCOS clinical features. Other specific associated genes may play a synergistic role, leading to heterogeneous pathophysiological changes. Additionally, the increased frequency of PCOS-risk alleles in women with single PCOS clinical features suggests that these subjects have an elevated risk of developing the syndrome, although they cannot be currently diagnosed. Study funding/competing interests: This research was supported by the National Basic Research Program of China (973 Program) (2012CB944700, 2011CB944502), the National Key Technology Research and Development Program(2011BAI17B00), the National Natural Science Foundation of China (81430029, 81201441, 81490743, 31371453), the Scientific Research Foundation of Shandong Province of Outstanding Young Scientist (2012BSE27089) and the Fundamental Research Funds of Shandong University(2014GN025). There were no competing interests.

Association of the Genetic Variants of Luteinizing Hormone, Luteinizing Hormone Receptor and Polycystic Ovary Syndrome

The Association Between Polymorphism Of Insr And Polycystic Ovary Syndrome: A Meta-Analysis

The Relationship Between the Polymorphisms of the Luteinizing Hormone Β Subunit ( LH Β) Gly102Ser and Polycystic Ovary Syndrome

Effect Modification of LHCGR Gene Variant (rs2293275) on Clinico-Biochemical Profile, and Levels of Luteinizing Hormone in Polycystic Ovary Syndrome Patients

The Relationship Between the Polymorphisms of the Luteinizing Hormone Receptor(lhr)and Polycystic Ovary Syndrome

Follicle Stimulating Hormone Receptor (FSHR) Polymorphisms and Polycystic Ovary Syndrome (PCOS)

Association Study between Polycystic Ovarian Syndrome and the Susceptibility Genes Polymorphisms in Hui Chinese Women

Relationship Between Polymorphism of CYP11A1 Gene and Polycystic Ovarian Syndrome

Variants in FSHB Are Associated with Polycystic Ovary Syndrome and Luteinizing Hormone Level in Han Chinese Women.

Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations

Statistical Genomic Approach Identifies Association between FSHR Polymorphisms and Polycystic Ovary Morphology in Women with Polycystic Ovary Syndrome

Association Between Polymorphisms of the CYP11A1 Gene and Polycystic Ovary Syndrome in Chinese Women

Systematic Evaluation of Genetic Variants for Polycystic Ovary Syndrome in a Chinese Population.

Lepr Gene Polymorphism and Plasma Soluble Leptin Receptor Levels Are Associated with Polycystic Ovary Syndrome in Han Chinese Women

Association of Rs13405728, Rs12478601, and Rs2479106 single nucleotide polymorphisms and in vitro fertilization and embryo transfer efficacy in patients with polycystic ovarian syndrome: A case control genome-wide association study

Heme oxygenase 2 genetic variants alter hormonal and metabolic traits in polycystic ovary syndrome

Replication study and meta-analysis of selected genetic variants and polycystic ovary syndrome susceptibility in Asian population

[Polymorphism of CYP11A1 Gene in Chinese Patients with Polycystic Ovarian Syndrome].

Prevalence of an immunological LH beta-subunit variant in a UK population of healthy women and women with polycystic ovary syndrome

Association between CYP19 gene SNP rs2414096 Polymorphism and polycystic ovary syndrome in Chinese women

Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature